How weight-loss injections are turning obesity into a wealth issue
UK access to weight-loss injections is uneven, creating a two-tier system where wealthier people obtain private prescriptions while many NHS patients miss out.
Novartis warns rising drug rebate rates and outdated assessment methods threaten UK patient access to new treatments and deter pharmaceutical investment.